Lanas F, Garcés E, Eggers G, Montecinos A, Díaz M, Gamboa C, Stockins B
Unidades de Cardiología, Universidad de La Frontera, Temuco, Chile.
Rev Med Chil. 1998 Mar;126(3):251-7.
There is not much evidence about the usefulness of digoxin or enalapril in the treatment of heart failure due to mitral insufficiency.
To compare digoxin and enalapril in the treatment of heart failure due to mitral insufficiency.
Patients with mitral insufficiency, in sinus rhythm, with a heart failure grade II or III and with echocardiographic left ventricular dilatation were eligible for the study. They received sequentially, during 12 weeks each, digoxin 0.25 mg/day or enalapril in doses up to 20 mg/day, with a washout in-between period of 2 weeks. The order of the sequence was determined randomly. At the start and end of treatment, functional class according to NYHA and maximal exercise tolerance in the treadmill were assessed and a color Doppler echocardiogram was done to measure ventricular dimensions, function and degree of mitral insufficiency.
Nine patients on enalapril and 12 on digoxin improved their functional capacity. Digoxin improved exercise time in 76 +/- 168 sec (p = 0.022), whereas this change was not significant with enalapril (38 +/- 158 sec; p = 0.2). With enalapril treatment, ventricular diastolic dimension decreased from 59.3 +/- 8.1 to 58 +/- 9.3 mm and the area of mitral insufficiency decreased from 8.1 +/- 3.5 to 6.6 +/- 3.1 cm2. Digoxin did not induce any significant echocardiographic change.
In these patients, digoxin and enalapril improved functional class. Digoxin improved exercise time and enalapril reduced ventricular dimensions and mitral insufficiency.
关于地高辛或依那普利在治疗二尖瓣关闭不全所致心力衰竭方面的有效性,证据不多。
比较地高辛和依那普利在治疗二尖瓣关闭不全所致心力衰竭中的效果。
窦性心律、心力衰竭分级为Ⅱ级或Ⅲ级且经超声心动图证实有左心室扩张的二尖瓣关闭不全患者符合本研究条件。他们在12周内依次接受治疗,分别为每天0.25毫克地高辛或剂量高达每天20毫克的依那普利,中间有2周的洗脱期。治疗顺序随机确定。在治疗开始和结束时,评估纽约心脏协会(NYHA)功能分级和跑步机上的最大运动耐量,并进行彩色多普勒超声心动图检查以测量心室大小、功能及二尖瓣关闭不全程度。
9例接受依那普利治疗的患者和12例接受地高辛治疗的患者心功能得到改善。地高辛使运动时间增加了76±168秒(p = 0.022),而依那普利治疗时这一变化不显著(38±158秒;p = 0.2)。接受依那普利治疗后,心室舒张末期内径从59.3±8.1毫米降至58±9.3毫米,二尖瓣反流面积从8.1±3.5平方厘米降至6.6±3.1平方厘米。地高辛未引起任何显著的超声心动图变化。
在这些患者中,地高辛和依那普利改善了功能分级。地高辛增加了运动时间,依那普利减小了心室大小并减轻了二尖瓣关闭不全。